Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wow, if you bought the crypto plays that I mentioned 3 weeks ago lol.
#meta ftw
SMURF is worth checking out also
Overdue for a run back over .20. It's coming.
Added some here. I'm also in $MANA.X and $SAND.X.
#meta ftw
I am actually with you 100% on this trade. I'm heavy in crypto right now, so I'm hoping this slowly bleeds down below .02, so I have time to accumulate possibly 5-10 million shares, maybe more haha. I plan to sell most of my crypto by EOY, so a few hundred k at least will be diverted to the cannabis sector.
Legislation/Decriminalization is realer than ever. I can taste it.
Fortune favors the bold.
Predicting another run-up to at least .20 within the next 6 months. Thanks for the .02 cheapies :)
Got myself 70k coins and ready for $10 by EOY if not more. If you haven't looked into Decentraland yet, I highly suggest you do so. (Not financial advice but the trend does look promising)
Me too lol. As they say, it ain't over until the fat lady sings.
Mostly the same for me. Crypto 90%, stocks 10%. I've begun to dca into MJ plays as well. Some of them getting to be historically really cheap.
Then you are in the know. Millionaires will be made and already have been made. Cheers.
Might want to check out the metaverse plays. I'm in heavy in both $MANA and $SAND, also $JASMY is worth checking out. GL
That's the thing, at least name the Vodka company. And so what about RSAMMD, is that deal dead now?
You don't have to tell me about forward looking OTC language...we all know how that game is played.
They can't be held liable should the deal fall apart either. Since they've excused themselves with "choice words".
Let's see what the week brings. If the deal doesn't close soon, the market will perceive that the deal is dead. In either case, TXTM will have to explain why the deal hasn't closed by the end of month...which I don't see happening.
Imagine if the RSAMMD deal should fall apart. Wouldn't be hard at all to imagine Tripville
None of the newcomers would know this, but if you've been following TXTM for a few years, you'd know that their definition of "soon" isn't at all what you and I would imagine it to be. "Soon" for them can be half a year or more. And "very soon" maybe even longer than that lol. Wouldn't be the first time. Hope I'm wrong.
What happened here today, why did it start to run? Lol...what a pop
I'm back in $MJNA "old faithful". She's gearing up again for another historic run, imho. Gltya
I wouldn't go so far as to say that there is "nothing left of the story". Suppose the JV deal with RSAMMD somehow falls through the cracks, they could again go dormant for a couple years and emerge with a new story lolz
There is money to be made with TXTM if follow the basic principles of trading: buy the fear and sell the cheer.
Shame they waited till the last possible minute to go current. Could have been a catalyst if they filed earlier in the year, but instead now it's nothing more than the status quo of the current regulatory environment. As everything in life, timing is everything.
At least since January 2021. It was definitely down a couple months before the spike to .008.
Geez, someone alerted me of this play when it was at .0020, but I didn't see their message till now, since I'm hardly on Investor's Hub.
Thanks for the heads up. Hope you banked hard on it. Please don't forget to take some profits, however. OTC market giveth and it taketh away very quickly. Profits don't count until you sell.
Perhaps it will go higher if TXTM actually goes current although with all the social media pumping going on, I don't want to stick around only to have the ticker suspended.
We all know that the SEC has been shutting down tickers that get pumped on social media without being current. The higher the volume the greater the risk. I'm not greedy. As the saying goes, "better the bird in the hand than two birds in a bush".
If they go current, I might get back in. But if not, adios for now.
Thanks for the pump. Sold my remaining TXTM shares today. Been around long enough to know that you and your croonies only post when it's time to sell.
Meh, wake me up when TXTM is current. Love to see the volume although it won't last if history repeats itself and there are no financials delivered. That stop sign needs to go first and foremost. Not impressed by Twitter pumpers trying to make a quick buck.
You and I both been around these neck of the woods for years. It would have been imprudent to not take any profit on the run we had in February. I will admit that I didn't sell nearly enough at the highs, but most definitely it was enough to pay myself for my time.
Got no stress now. If the reverse merger gets finalized, still got some skin in the game for the next pump.
And yes, I can post screenshots to that effect. I will PM you one of these Fridays during the free PM hour. I ain't gonna pay for a subscription to IH, since I'm not on here often. No point.
Tbh I sold most of my $TXTM on the last run. I'm riding for free now, but I might sell it all if financials don't get released by May.
It's disappointing that they can't stick to their own timeline. Everybody in business knows that you build trust and confidence by projecting a deadline and then delivering results before that deadline that you set. When you say that financials will be submitted to OTCM by mid-March and it doesn't happen then, only thing that will do is cause investors to lose confidence.
This is the pink sheets, so kinda goes with the territory.
I've avoided penny stocks and have been much happier. The crypto market has been treating me well. I rarely post on IH, since I don't trade penny stocks any longer.
I am active on Stocktwits talking about crypto if anyone is interested to know my thoughts. I've discovered some solid crypto plays that been making consistent money. My username is LaDolceVita7 on Stocktwits.
$TXTM financials being worked on as per Twitter:
$TXTM
— HugeTrips (@HugeTrips) April 15, 2021
Pink is right behind the corner.
Check out what Mr. Lewis answered when I asked him about getting pink. pic.twitter.com/5BDSCGHatR
A shell with proven IP that is.
It's much cheaper to reverse merge into an existing shell than to IPO.
If/when RSAMMD reverse mergers into $TXTM shell, we could very well be trading at dollars overnight. Keep this mind, if a reverse merger happens, RSAMMD's books will no longer be private. The market will be shocked when audited financials show billions in annual sales.
HODL for dear life my friend. Would be a shame to follow $TXTM for years and miss the ride of a lifetime.
Could be a perfect storm. If we go current as the people get their stimulus money, we may just retest the .0080 from a few weeks ago.
If I were the market maker that's been shorting this stock, I'd hurry TF up and cover before the Reddit/Robinhood crowd get here. Cover or lose money. They will get their butts handed them when the news drops. They didn't learn from last time. The populist investor movement is here to stay.
$TXTM It's not a coincidence that RSAMMD will be in attendance at the cannabis expo taking place in Mexico. Mexico is set to become the $$largest legal $$cannabis $$market in the world. RSAMMD with $TXTM live plant extraction tech will take the world by storm in 2021. Follow the $$$money
https://www.nbcnews.com/news/world/mexico-moves-closer-becoming-world-s-largest-legal-cannabis-market-n1259519
The Senate passed the stimulus package today, so who knows, a perfect storm just may take $SANP to .10 before it comes back down to reality. There will be some folks holding heavy bags then. To each their own.
Flippers will be happy, everyone else, not so much.
Wishful thinking. My comments of concern would never affect the price. SANP is being pumped hard right now. I know this cause it came to my attention on Stocktwits while I was reading the ADA board there. So many were posting there trying to promote their stock. Smells of desparation tbh.
Needless to say, I'm invested heavily in Cardano / ADA. Very rarely do I get involved with penny stocks anymore.
I may flip this or I may not. One thing is for certain, I won't touch it until the stop sign gets removed. With all the promoting going on social media for SANP, there is a real risk of a SEC suspension.
I wish everyone luck here. There is money to be made, but let's keep it realistic. Saying that is going to $1 is a pipe dream.
$SANP don't get stuck. Flip, make a buck and be happy. I haven't seen it mentioned here by any of the pie in the sky pumpers, but the reality is, there are 2074 staking pools for ADA already.
Competition is fierce and gaining market share ain't going to be easy. I saw it mentioned somewhere that their purported ROA rate would be 1.5% ? If that is true, this will go nowhere but up in flames.
https://adapools.org/
$TXTM NEWS
March 04, 2021, 16:08 GMT
SHARE THIS ARTICLE
https://www.einpresswire.com/article/536330550/protext-mobility-provides-shareholders-update
FLORIDA, UNITED STATES, March 4, 2021 /EINPresswire.com/ -- PROTEXT MOBILITY PROVIDES SHAREHOLDERS UPDATE
Protext Mobility, Inc (AKA Protext Pharma, Inc.) (OTCPINK: TXTM) ("Protext" or "the Company"), today provided the following update to shareholders and the public in general.
The Company has recently engaged with a CPA firm to update the company financials for the annual periods ending 2019 and 2020. It is anticipated to be completed by mid-March. The company has recently submitted an application with OTC Markets for listing current financial information and posting of its updated financials for the periods ending 2019 and 2020.
On May 30th, 2019, Roger Duffield resigned as CEO and Director of the Company, stating health reasons for his departure. David Lewis, Executive Director took on the position of acting CEO as of May 30th, 2019.
In Q2, 2020 the Company settled a breach of agreement caused by Plandai Biotechnology, Inc (OTC PINK (PLPL) relating to the Plan of Exchange dated Dec.31, 2016 whereby Protext had acquired 100% interest in Plandai Biotechnology, SA from Plandai Biotechnology, Inc. The parties agreed to cancel in its entirety the control block of 100,000 shares of Series D preferred stock payable to Plandai (PLPL). The parties further agreed that the balance of the Agreement and terms of the Plan of Exchange, including all licenses and other assets transferred to Protext through Plandai Biotechnology SA (a wholly owned subsidiary of Protext) shall remain intact with Protext retaining 100% interest in its wholly owned subsidiary Plandai Biotechnology, SA.
In Q2, 2020, the Company settled a breach of agreement caused by Plandai Biotechnology, Inc (OTC PINK (PLPL) relating to the Plan of Exchange dated March 14th, 2017 whereby Protext acquired 100% ownership of Cannabis Biosciences, Inc from Plandai (PLPL) in exchange for 50,000,000 restricted common shares of Protext (TXTM). The parties agreed to reduce the 50,000,000 shares of Protext common stock payable to Plandai, to 10,000,000 shares of Protext restricted common stock payable to Plandai Biotechnology (PLPL). It was further agreed that the transaction and accompanying licenses held by Cannabis Biosciences will remain intact and property of Protext. As part of the settlement, Plandai provided the Company with all necessary blueprints, drawings, designs, schematics, processes and IP such that Protext can design, build and/or execute partnership agreements with industry participants to commercialize an industrial scale Kettle system together with related extraction processes developed by Plandai and/or its subsidiaries and Mr.Duffield for completing an end product to be brought to market.
About Protext
Protext operates two wholly owned subsidiaries; Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc. Twitter: https://twitter.com/protxtm
Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. The company disclaims any obligation to update information contained in any forward-looking statement. This press release shall not be deemed a general solicitation.
David Lewis
Protext Mobility, Inc.
email us here
$TXTM NEWS
March 04, 2021, 16:08 GMT
SHARE THIS ARTICLE
https://www.einpresswire.com/article/536330550/protext-mobility-provides-shareholders-update
FLORIDA, UNITED STATES, March 4, 2021 /EINPresswire.com/ -- PROTEXT MOBILITY PROVIDES SHAREHOLDERS UPDATE
Protext Mobility, Inc (AKA Protext Pharma, Inc.) (OTCPINK: TXTM) ("Protext" or "the Company"), today provided the following update to shareholders and the public in general.
The Company has recently engaged with a CPA firm to update the company financials for the annual periods ending 2019 and 2020. It is anticipated to be completed by mid-March. The company has recently submitted an application with OTC Markets for listing current financial information and posting of its updated financials for the periods ending 2019 and 2020.
On May 30th, 2019, Roger Duffield resigned as CEO and Director of the Company, stating health reasons for his departure. David Lewis, Executive Director took on the position of acting CEO as of May 30th, 2019.
In Q2, 2020 the Company settled a breach of agreement caused by Plandai Biotechnology, Inc (OTC PINK (PLPL) relating to the Plan of Exchange dated Dec.31, 2016 whereby Protext had acquired 100% interest in Plandai Biotechnology, SA from Plandai Biotechnology, Inc. The parties agreed to cancel in its entirety the control block of 100,000 shares of Series D preferred stock payable to Plandai (PLPL). The parties further agreed that the balance of the Agreement and terms of the Plan of Exchange, including all licenses and other assets transferred to Protext through Plandai Biotechnology SA (a wholly owned subsidiary of Protext) shall remain intact with Protext retaining 100% interest in its wholly owned subsidiary Plandai Biotechnology, SA.
In Q2, 2020, the Company settled a breach of agreement caused by Plandai Biotechnology, Inc (OTC PINK (PLPL) relating to the Plan of Exchange dated March 14th, 2017 whereby Protext acquired 100% ownership of Cannabis Biosciences, Inc from Plandai (PLPL) in exchange for 50,000,000 restricted common shares of Protext (TXTM). The parties agreed to reduce the 50,000,000 shares of Protext common stock payable to Plandai, to 10,000,000 shares of Protext restricted common stock payable to Plandai Biotechnology (PLPL). It was further agreed that the transaction and accompanying licenses held by Cannabis Biosciences will remain intact and property of Protext. As part of the settlement, Plandai provided the Company with all necessary blueprints, drawings, designs, schematics, processes and IP such that Protext can design, build and/or execute partnership agreements with industry participants to commercialize an industrial scale Kettle system together with related extraction processes developed by Plandai and/or its subsidiaries and Mr.Duffield for completing an end product to be brought to market.
About Protext
Protext operates two wholly owned subsidiaries; Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc. Twitter: https://twitter.com/protxtm
Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. The company disclaims any obligation to update information contained in any forward-looking statement. This press release shall not be deemed a general solicitation.
David Lewis
Protext Mobility, Inc.
email us here
$TXTM NEWS
March 04, 2021, 16:08 GMT
SHARE THIS ARTICLE
https://www.einpresswire.com/article/536330550/protext-mobility-provides-shareholders-update
FLORIDA, UNITED STATES, March 4, 2021 /EINPresswire.com/ -- PROTEXT MOBILITY PROVIDES SHAREHOLDERS UPDATE
Protext Mobility, Inc (AKA Protext Pharma, Inc.) (OTCPINK: TXTM) ("Protext" or "the Company"), today provided the following update to shareholders and the public in general.
The Company has recently engaged with a CPA firm to update the company financials for the annual periods ending 2019 and 2020. It is anticipated to be completed by mid-March. The company has recently submitted an application with OTC Markets for listing current financial information and posting of its updated financials for the periods ending 2019 and 2020.
On May 30th, 2019, Roger Duffield resigned as CEO and Director of the Company, stating health reasons for his departure. David Lewis, Executive Director took on the position of acting CEO as of May 30th, 2019.
In Q2, 2020 the Company settled a breach of agreement caused by Plandai Biotechnology, Inc (OTC PINK (PLPL) relating to the Plan of Exchange dated Dec.31, 2016 whereby Protext had acquired 100% interest in Plandai Biotechnology, SA from Plandai Biotechnology, Inc. The parties agreed to cancel in its entirety the control block of 100,000 shares of Series D preferred stock payable to Plandai (PLPL). The parties further agreed that the balance of the Agreement and terms of the Plan of Exchange, including all licenses and other assets transferred to Protext through Plandai Biotechnology SA (a wholly owned subsidiary of Protext) shall remain intact with Protext retaining 100% interest in its wholly owned subsidiary Plandai Biotechnology, SA.
In Q2, 2020, the Company settled a breach of agreement caused by Plandai Biotechnology, Inc (OTC PINK (PLPL) relating to the Plan of Exchange dated March 14th, 2017 whereby Protext acquired 100% ownership of Cannabis Biosciences, Inc from Plandai (PLPL) in exchange for 50,000,000 restricted common shares of Protext (TXTM). The parties agreed to reduce the 50,000,000 shares of Protext common stock payable to Plandai, to 10,000,000 shares of Protext restricted common stock payable to Plandai Biotechnology (PLPL). It was further agreed that the transaction and accompanying licenses held by Cannabis Biosciences will remain intact and property of Protext. As part of the settlement, Plandai provided the Company with all necessary blueprints, drawings, designs, schematics, processes and IP such that Protext can design, build and/or execute partnership agreements with industry participants to commercialize an industrial scale Kettle system together with related extraction processes developed by Plandai and/or its subsidiaries and Mr.Duffield for completing an end product to be brought to market.
About Protext
Protext operates two wholly owned subsidiaries; Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc. Twitter: https://twitter.com/protxtm
Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. The company disclaims any obligation to update information contained in any forward-looking statement. This press release shall not be deemed a general solicitation.
David Lewis
Protext Mobility, Inc.
email us here
$TXTM NEWS
March 04, 2021, 16:08 GMT
SHARE THIS ARTICLE
https://www.einpresswire.com/article/536330550/protext-mobility-provides-shareholders-update
FLORIDA, UNITED STATES, March 4, 2021 /EINPresswire.com/ -- PROTEXT MOBILITY PROVIDES SHAREHOLDERS UPDATE
Protext Mobility, Inc (AKA Protext Pharma, Inc.) (OTCPINK: TXTM) ("Protext" or "the Company"), today provided the following update to shareholders and the public in general.
The Company has recently engaged with a CPA firm to update the company financials for the annual periods ending 2019 and 2020. It is anticipated to be completed by mid-March. The company has recently submitted an application with OTC Markets for listing current financial information and posting of its updated financials for the periods ending 2019 and 2020.
On May 30th, 2019, Roger Duffield resigned as CEO and Director of the Company, stating health reasons for his departure. David Lewis, Executive Director took on the position of acting CEO as of May 30th, 2019.
In Q2, 2020 the Company settled a breach of agreement caused by Plandai Biotechnology, Inc (OTC PINK (PLPL) relating to the Plan of Exchange dated Dec.31, 2016 whereby Protext had acquired 100% interest in Plandai Biotechnology, SA from Plandai Biotechnology, Inc. The parties agreed to cancel in its entirety the control block of 100,000 shares of Series D preferred stock payable to Plandai (PLPL). The parties further agreed that the balance of the Agreement and terms of the Plan of Exchange, including all licenses and other assets transferred to Protext through Plandai Biotechnology SA (a wholly owned subsidiary of Protext) shall remain intact with Protext retaining 100% interest in its wholly owned subsidiary Plandai Biotechnology, SA.
In Q2, 2020, the Company settled a breach of agreement caused by Plandai Biotechnology, Inc (OTC PINK (PLPL) relating to the Plan of Exchange dated March 14th, 2017 whereby Protext acquired 100% ownership of Cannabis Biosciences, Inc from Plandai (PLPL) in exchange for 50,000,000 restricted common shares of Protext (TXTM). The parties agreed to reduce the 50,000,000 shares of Protext common stock payable to Plandai, to 10,000,000 shares of Protext restricted common stock payable to Plandai Biotechnology (PLPL). It was further agreed that the transaction and accompanying licenses held by Cannabis Biosciences will remain intact and property of Protext. As part of the settlement, Plandai provided the Company with all necessary blueprints, drawings, designs, schematics, processes and IP such that Protext can design, build and/or execute partnership agreements with industry participants to commercialize an industrial scale Kettle system together with related extraction processes developed by Plandai and/or its subsidiaries and Mr.Duffield for completing an end product to be brought to market.
About Protext
Protext operates two wholly owned subsidiaries; Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc. Twitter: https://twitter.com/protxtm
Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. The company disclaims any obligation to update information contained in any forward-looking statement. This press release shall not be deemed a general solicitation.
David Lewis
Protext Mobility, Inc.
email us here
$TXTM The departments of health and agriculture have now issued permits to cultivate industrial hemp on 5,000ha. "This makes it the world's largest licensed commercial cannabis sativa farm," said Thaver.
https://www.timeslive.co.za/news/south-africa/2018-12-19-kzn-farmer-grows-1000ha-of-cannabis-but-you-cant-smoke-it/
I will show you when I sell my shares. I'm holding until $TXTM hits paper. Prepare to have you mind blown. A reverse merger of a billion dollar company is about to come into $TXTM shell. RSAMMD wants to go public through TXTM and will acquire Protext extraction tech IP.
#Game Changer
#Diamond Hands
#TXTMillionaire
$TXTM "anticipated to go current by mid-March"... If that happens, will you leave this board forever?
This about to get very real. Buckle up